Anti-inflammatory action of cholecystokinin and melatonin in the rat parotid gland

Oral Diseases

Volumn 16, Issue 7, 2010, Pages 661-667

  Evik Aras, H ^a   Ekstrom J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

anti inflammatory; cholecystokinin; lipopolysaccharide induced salivary gland inflammation; melatonin; myeloperoxidase activity; nitric oxide synthase inhibitors

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLECYSTOKININ OCTAPEPTIDE; ITRIGLUMIDE; LORGLUMIDE; LUZINDOLE; MELATONIN; MYELOPEROXIDASE; NEURONAL NITRIC OXIDE SYNTHASE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAROTID GLAND; PRIORITY JOURNAL; RAT; SALIVARY GLAND;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ESCHERICHIA COLI; HORMONE ANTAGONISTS; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; LYSINE; MELATONIN; NEUTROPHIL INFILTRATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; PARASYMPATHECTOMY; PAROTID GLAND; PAROTITIS; PEROXIDASE; PROGLUMIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, MELATONIN, MT2; SINCALIDE; SYMPATHECTOMY; TRYPTAMINES;

EID: 77956824380     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01672.x     Document Type: Article

References (39)

1. Alm P, Ekström J (1977). On the adrenergic innervation of the rat parotid gland. Experientia 33 : 523 524.
2. Barlas A, evik H, Arbak S et al (2004). Melatonin protects against pancreaticobiliary inflammation and associated remote organ injury in rats: role of neutrophils. J Pineal Res 37 : 267 275.
3. Bradley PP, Priebat DA, Christersen RD, Rothstein G (1982). Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 : 206 209.
4. Carrasco M, Del Rio MD, Hernanz A, Fuente MDL (1997). Inhibition of human neutrophil functions by sulfated and nonsulfated cholecystokinin octapeptides. Peptides 18 : 415 422.
5. evik-Aras H, Ekström J (2006a). Cholecystokinin-and gastrin-induced protein and amylase secretion from the parotid gland of the anaesthetized rat. Reg Pept 134 : 89 96.
6. evik-Aras H, Ekström J (2006b). Pentagastrin-induced protein synthesis in the parotid gland of the anaesthetized rat, and its dependence on CCK-A and -B receptors and nitric oxide generation. Exp Physiol 91 : 673 679.
7. evik-Aras H, Ekström J (2006c). Pentagastrin-induced nitric oxide-dependent protein secretion from the parotid gland of the anaesthetized rat. Exp Physiol 91 : 977 982.
8. evik-Aras H, Ekström J (2008). Melatonin-evoked in vivo secretion of protein and amylase from the parotid gland of the anaesthetised rat. J Pineal Res 45 : 413 421.
9. Crespo E, Macías M, Pozo D et al (1999). Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 13 : 1537 1546.
10. Cutando A, Arana C, Gomez-Moreno G et al (2007). Local application of melatonin into alveolar sockets of beagle dogs reduces tooth removal-induced oxidative stress. J Periodontol 78 : 576 583.
11. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabo C (1997). Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 23 : 106 116.
12. Czesnikiewics-Guzik M, Konturek SJ, Loster B, Wisniewska G, Majewski S (2007). Melatonin and its role in oxidative stress related diseases of oral cavity. J Physiol Pharmacol 58 (Suppl 3 5 19.
13. Darnell M, evik-Aras H, Magnusson B, Ekström J (2006). Lipopolysaccharide induced-in vivo increases in ß-defensins of the rat parotid gland. Arch Oral Biol 51 : 769 774.
14. Dubocovich ML, Yun K, Al-Ghoul WM, Benloucif S, Masana MI (1998). Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 12 : 1211 1220.
15. Ekström J, evik-Aras H, Sayardoust S (2007). Neuronal-and hormonal-induced protein synthesis and mitotic activity in the rat parotid gland and the dependence on NO-generation. J Oral Biosci 49 : 31 38.
16. Giannoulia-Karantana A, Vlachou A, Polychronopoulou S, Papassotiriou I, Chrousos GP (2006). Melatonin and immunomodulation: connections and potential clinical applications. Neuroimmunomodulation 13 : 133 144.
17. Gòmez-Moreno G, Guardia J, Ferrera MJ, Cutando A, Reiter RJ (2009). Melatonin in diseases of the oral cavity. Oral Dis DOI :.
18. Griius MM, Fox PC (1998). Salivary gland disfunction and xerostomia. In : Linden RWA, ed. The scientific basis of eating, Vol. 9. Front Oral Biol Karger :
19. Hillegas LM, Griswold DE, Brickson B, Albrightson-Winslow C (1990). Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 24 : 285 295.
20. Ingenito A, Catelani C, Mercaldo A, d′Agata A, Cappelli G, Andreoli F (1986). Radioimmunoassay of gastrin in human saliva. Eur Surg Res 18 : 129 132.
21. Jahovic N, evik H, Sehirli AÖ, Yegen B (2003). Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 34 : 282 287.
22. Khosravani N, Sandberg M, Ekström J (2006). The otic ganglion in rats and its parotid connection: cholinergic pathways, reflex secretion and a secretory role for the facial nerve. Exp Physiol 91 : 239 247.
23. Konturek PCH, Brzozowski T, Sliwowski Z, Pajdo R, Stachura J, Hahn EG (1998). Involvement of nitric oxide and prostaglandins in gastroprotection induced by bacterial lipopolysaccharide. Scan J Gastroenterol 33 : 691 700.
24. Korkmaz A, Reiter RJ, Topal T, Manhester LC, Öter S, Tan DX (2009). Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15 : 43 50.
25. Kuebler WM, Abels C, Schuerer L, Goetz AE (1996). Measurement of neutrophil content in brain and lung tissue by a modified myeloperoxidase assay. Int J Microcirc 16 : 89 97.
26. Laakso ML, Porkka-Heiskanen T, Alila A, Stenberg D, Johansson G (1990). Correlation between salivary and serum melatonin: dependence on serum melatonin levels. J Pineal Res 9 : 39 50.
27. Ling LY, Meng AH, Zhao XY, Shan BE, Zhang JL, Zhang XP (2001). Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J Gastroenterol 7 : 667 671.
28. Lomniczi A, Mohn C, Faletti A et al (2001). Inhibition of salivary secretion by lipopolysaccharide: possible role of prostaglandins. Am J Physiol Endocrinol Metab 281 : E405 E411.
29. Morris MS, Billiar TR (1994). New insight into the regulation of inducible nitric oxide synthesis. Am J Physiol 266 : E829 E839.
30. Reiter RJ (2003). Melatonin: clinical relevance. Best Pract & Res Clin Endocrinol and Metab 17 : 273 285.
31. Reiter RJ, Tan DX, Osuna C, Gitto E (2000a). Actions of melatonin in the reduction of oxidative stress. J Biomed Sci 7 : 444 458.
32. Reiter RJ, Calvob JR, Karbownik M, Qi W, Tan DX (2000b). Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 917 : 376 386.
33. Reiter JR, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S (2002). Melatonin: in reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 54 : 1299 1321.
34. Sewerynek E, Reiter RJ, Melchiorri G, Ortiz G, Lewinski A (1996). Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 43 : 898 905.
35. Slomiany BL, Slomiany A (2002). Porphyromonas gingivalis lipopolysaccharide interferes with salivary mucin synthesis through inducible nitric oxide synthase activation by ERK and p38 kinase. Biochem Biophys Res Commun 297 : 1149 1153.
36. Thomas EL, Jefferson MM, Joyner RE, Cook GS, King CC (1994). Leukocyte myeloperoxidase and salivary lactoperoxidase: Identification quantitation in human mixed saliva. J Den Res 73 : 544 555.
37. Topal T, Öztas Y, Korkmaz A et al (2005). Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res 38 : 272 277. (Pubitemid 41475439)
38. Wu CC, Chiao CW, Hsiao G, Chen A, Yen MH (2001). Melatonin prevents endotoxin-Iinduced circulatory failure in rats. J Pineal Res 30 : 147 156.
39. Wu SV, Harikumar KG, Burgess RJ, Reeve JR Jr., Miller LJ (2008). Effects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulation. Am J Physiol Gastrointest Liver Physiol 295 : G641 G647.